Postpartum psychosis in mothers with SARS-CoV-2 infection: A case series from India

Subramanyam, Alka A; Nachane, Hrishikesh B; Mahajan, Niraj N.; Shinde, Snehal; Mahale, Smita D.; Gajbhiye, Rahul

doi:10.1016/j.ajp.2020.102406

Cited by 20 publications

(14 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Although a risk of postpartum psychosis has been reported among women with COVID-19, 12 no such events were detected among the 20 women with MGP in the present study, suggesting that women with MGP may not be at an increased risk of postpartum psychosis.…”

Section: Discussioncontrasting

confidence: 84%

Impact of SARS‐CoV‐2 on multiple gestation pregnancy

Mahajan

Ansari

Gaikwad

et al. 2020

Intl J Gynecology & Obste

Self Cite

View full text Add to dashboard Cite

The incidence of multiple pregnancies varies in different populations and countries. Twinning rates in India are reported to be below 9 per 1000 births. 1 As of October 20, 2020 SARS-CoV-2 (COVID-19) had affected approximately 40 million individuals globally and caused more than 1 million deaths, 2 including many pregnant women with twin gestation. Multiple gestational pregnancies (MGP) are associated with a high risk of both fetal and maternal complications and require

show abstract

Section: Discussioncontrasting

confidence: 84%

Impact of SARS‐CoV‐2 on multiple gestation pregnancy

Mahajan

Ansari

Gaikwad

et al. 2020

Intl J Gynecology & Obste

Self Cite

View full text Add to dashboard Cite

show abstract

“…Considering the COVID-19 reaching the tribal and rural parts of India, both public and private healthcare systems should be strengthened for diagnosis and appropriate management of co-infections. Documentation of post-partum psychosis in mothers with COVID-19 [21] is useful for creating awareness and providing appropriate mental health care for pregnant and postpartum women with COVID-19.…”

Section: Discussionmentioning

confidence: 99%

“…Coronavirus disease 2019 (COVID-19) has emerged as a public health emergency with more than 103 million confirmed cases of COVID-19, including 2.3 million deaths, worldwide as [1].…”

Section: Introductionmentioning

confidence: 99%

Protocol for a prospective, hospital-based registry of pregnant women with SARS-CoV-2 infection in India: PregCovid Registry study

Gajbhiye

Mahajan

Waghmare

et al. 2021

Preprint

Self Cite

View full text Add to dashboard Cite

Introduction: Pregnant women are at increased risk of contracting coronavirus disease 2019 (COVID-19) due to several factors and therefore require special attention. However, consequences of the COVID-19 pandemic on pregnant women and their newborns remain uncharted. The aim of PregCovid registry is to document the impact of SARS-CoV-2 infection on pregnant, post-partum women and their new-borns. The aim of the registry is also to determine mother to child transmission of SARS-CoV-2 infection in India. Methods and analysis: PregCovid is a hospital based registry for capturing information of pregnant, post-partum women with COVID-19 and their new-borns in India. Medical case records of pregnant and post-partum women with laboratory confirmed diagnosis of COVID-19 will be captured in real time using an online electronic patient record (EPR) software. The frequency of each symptom will be calculated. The laboratory data will be analyzed for calculating the frequency of laboratory parameters consistently higher in women with COVID-19. The adverse pregnancy and neonatal outcomes will be analyzed and their frequency will be calculated. Response to treatment will be analyzed for frequency calculation (number of women treated with different treatment regimens). The mother to child transmission data will be analyzed from the RT-PCR and/ antibody data of neonatal and maternal samples tested wherever the information is available. The registry data will be crucial for developing strategies for reducing the adverse impact of COVID-19 on pregnant women and their new-born. Ethics and dissemination: The study is approved by the Institutional Ethics Committee of ICMR-National Institute for Research in Reproductive Health (#55/2020), BYL Nair Hospital, Mumbai, India (# 63/2020); and all the 18 participating study sites under Medical Education and Drugs Department of Government of Maharashtra. The Institutional Ethics Committees granted a waiver of consent as the data is collected from the medical case records. Trial registration number: CTRI/2020/05/025423

show abstract

“…In these women, increased anxiety and psychological distress related to COVID-19 was observed (unpublished data). Three cases of post-partum psychosis associated with COVID-19 were successfully managed at our dedicated COVID-19 hospital ( Mahajan et al, 2020 ; Subramanyam et al, 2020 ).…”

mentioning

confidence: 99%